Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$36,236,693
+$457,278 QoQ
Shares Held
142,681
-2.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#529
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOKF, NA holds $220,983,153 across 10 Drug Manufacturers - General names. JNJ ranks #3 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,087 | $61,275,284 | |
| 2 | ABBV |
AbbVie Inc.
|
194,942 | $49,055,203 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
142,681 | $36,236,693 | |
| 4 | AMGN |
Amgen Inc
|
67,477 | $24,434,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
136,461 | $17,240,482 | |
| 6 | MRK |
Merck & Co., Inc.
|
114,907 | $14,765,549 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
244,226 | $14,072,301 | |
| 8 | PFE |
Pfizer Inc
|
82,045 | $1,975,643 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,236,693 | 142,681 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $35,779,415 | 146,373 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $32,075,386 | 154,991 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $31,173,366 | 168,123 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $28,219,798 | 184,745 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $30,957,850 | 186,673 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $28,128,734 | 194,501 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,899,727 | 196,839 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $29,354,627 | 200,839 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $39,980,623 | 252,738 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $40,006,787 | 255,243 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $42,128,972 | 270,491 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $48,825,916 | 294,985 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $47,218,580 | 304,636 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $62,380,767 | 353,132 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $60,937,690 | 373,027 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $66,557,729 | 374,952 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $64,943,806 | 366,438 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $65,782,915 | 384,538 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $62,293,134 | 385,716 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $54,899,308 | 334,039 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $54,018,638 | 343,237 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $71,138,883 | 477,827 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $58,569,019 | 416,476 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $52,791,494 | 402,589 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||